Edelweiss MSCI I D W H 45 Index Fund G
Summary Info
Fund Name
: Edelweiss Mutual Fund
Scheme Name
: Edelweiss MSCI I D W H 45 Index Fund G
AMC
: Edelweiss Mutual Fund
Type
: Open
Category
: Equity - Index
Launch Date
: 06-Oct-2020
Fund Manager
: Bhavesh Jain
Net Assets (Rs. cr)
: 163.38
Edelweiss MSCI I D W H 45 Index Fund G - Nav Details
Nav Date
: 16-Sep-2025
NAV [Rs.]
: 19.885
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Edelweiss MSCI I D W H 45 Index Fund G- NAV Chart
Edelweiss MSCI I D W H 45 Index Fund G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.72 | 0.78 | 2.04 | 7.55 | -2.29 | 18.98 | - | 15.06 |
| Category Avg | 1.92 | 3.22 | 1.08 | 17.04 | -3.07 | 16.39 | 18.45 | 10.12 |
| Category Best | 8.35 | 12.57 | 16.78 | 47.74 | 31.07 | 33.62 | 27.31 | 35.11 |
| Category Worst | -0.2 | -2.13 | -10.41 | 0.74 | -15.99 | 10.38 | 15.61 | -18.9 |
Edelweiss MSCI I D W H 45 Index Fund G- Latest Dividends
No Records Found
Edelweiss MSCI I D W H 45 Index Fund G- Investment Details
Min. Investment(Rs.)
: 100
Increm.Investment(Rs.)
: 100
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.84 | 111062 | 17.70 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.36 | 65421 | 10.39 |
| Equity | Max Healthcare | Healthcare Services | 6.36 | 89999 | 10.38 |
| Equity | Apollo Hospitals | Healthcare Services | 5.43 | 11647 | 8.86 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.21 | 67595 | 8.51 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 5.19 | 13824 | 8.47 |
| Foreign Equity | ELI LILLY & CO | Pharmaceuticals | 5.01 | 1272 | 8.18 |
| Foreign Equity | JOHNSON & JOHNSON | Pharmaceuticals | 3.62 | 3800 | 5.91 |
| Equity | Fortis Health. | Healthcare Services | 3.17 | 56787 | 5.17 |
| Foreign Equity | ABBVIE INC | Biotechnology | 3.16 | 2792 | 5.16 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 3.06 | 26417 | 5.00 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.99 | 13708 | 4.87 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.17 | 14323 | 3.53 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 2.13 | 40562 | 3.47 |
| Foreign Equity | NOVARTIS AG | Pharmaceuticals | 2.04 | 2998 | 3.33 |
| Foreign Equity | ABBOTT LABORATORIES | Health Care Equipment & Supplies | 1.95 | 2735 | 3.18 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.92 | 16328 | 3.14 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.90 | 30245 | 3.10 |
| Foreign Equity | MERCK & CO.INC | Pharmaceuticals | 1.79 | 3968 | 2.93 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 1.75 | 29111 | 2.85 |
| Foreign Equity | THERMO FISHER SCIENTIFIC INC | Life Sciences Tools & Services | 1.58 | 595 | 2.57 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.57 | 4843 | 2.56 |
| Foreign Equity | Novo Nordisk A/S | Pharmaceuticals & Biotechnology | 1.52 | 5007 | 2.48 |
| Foreign Equity | INTUITIVE SURGICAL INC | Health Care Equipment & Supplies | 1.44 | 564 | 2.34 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.37 | 16148 | 2.23 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.32 | 61886 | 2.15 |
| Foreign Equity | AMGEN INC | Biotechnology | 1.31 | 846 | 2.13 |
| Foreign Equity | GILEAD SCIENCES INC | Biotechnology | 1.19 | 1964 | 1.94 |
| Foreign Equity | STRYKER CORP | Health Care Equipment & Supplies | 1.14 | 541 | 1.86 |
| Foreign Equity | DANAHER CORP | Health Care Equipment & Supplies | 1.13 | 1019 | 1.84 |
| Foreign Equity | MEDTRONIC PLC | Health Care Equipment & Supplies | 1.01 | 2022 | 1.64 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 0.98 | 8580 | 1.60 |
| Equity | Narayana Hrudaya | Healthcare Services | 0.89 | 8277 | 1.45 |
| Foreign Equity | VERTEX PHARMACEUTICALS INC | Biotechnology | 0.85 | 404 | 1.38 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 0.84 | 4901 | 1.36 |
| Equity | Syngene Intl. | Healthcare Services | 0.80 | 20962 | 1.31 |
| Equity | Global Health | Healthcare Services | 0.78 | 9324 | 1.28 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 0.78 | 69038 | 1.26 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 0.77 | 5059 | 1.25 |
| Equity | Cohance Life | Pharmaceuticals & Biotechnology | 0.64 | 11784 | 1.03 |
| Foreign Equity | Regeneron Pharmaceuticals Inc | Pharmaceuticals | 0.52 | 168 | 0.85 |
| Foreign Equity | BECTON DICKINSON & CO | Health Care Equipment & Supplies | 0.46 | 448 | 0.75 |
| Foreign Equity | AGILENT TECHNOLOGIES INC | Life Sciences Tools & Services | 0.30 | 447 | 0.49 |
| Foreign Equity | IQVIA HOLDINGS INC | Life Sciences Tools & Services | 0.28 | 277 | 0.46 |
| Foreign Equity | ILLUMINA INC | Life Sciences Tools & Services | 0.13 | 247 | 0.21 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | C C I | -/- | 0.39 | 0 | 0.62 |
| Cash & Cash Equivalent | Accrued Interest | -/- | 0.00 | 0 | 0.00 |
| Net CA & Others | Net CA & Others | -/- | -0.04 | 0 | -0.05 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Edelweiss Mutual Fund
Incorporation Date:
23-Aug-2007
Total Assets Managed (Cr.):
1,70,254.52
Trustee/s:
Eedelweiss Trusteeship Co
Chairman:
Rujan Panjwani
CEO / MD:
Ms. Radhika Gupta
CIO:
NA
President:
NA
Director/s:
Sandeep Bhandarker, Mr.Bhavesh Jain
Compliance Officer/s:
Mr. Jehzeel Master
Investor Service Officer/s:
Mr. Abdulla Chaudhari
Fund Manager/s:
Bhavesh Jain
Auditors:
Nangia & CO LLP(Edelweiss, Walker Chandiok & Co LLP
OTHER INFORMATION
Registered Office:
Edelwiess House, Off.C.S.T. Road, Kalina, Mumbai - 400 098.
Contact Nos:
022 40979737
Fax:
022 40979878
Email:
Website:
